Cargando…
Why the length of recurrence-free survival or ‘lead-times’ can be misleading. Comment on: Callesen LB, Takacova T, Hamfjord J, et al. Circulating DNA in patients undergoing loco-regional treatment of colorectal cancer metastases: a systematic review and meta-analysis
Autor principal: | Sorscher, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028620/ https://www.ncbi.nlm.nih.gov/pubmed/36960320 http://dx.doi.org/10.1177/17588359231156383 |
Ejemplares similares
-
Time for a lead-time definition? Author response to ‘Why the length
of recurrence free survival or “lead-times” can be misleading. Comment on:
Callesen LB, Takacova T, Hamfjord J, et al. Circulating DNA in patients
undergoing loco-regional treatment of colorectal cancer metastases: a systematic
review and meta-analysis’
por: Spindler, Karen-Lise Garm, et al.
Publicado: (2023) -
EUFOREA Comment on a Misleading Allergic Rhinitis Report [Letter]
por: Scadding, Glenis K, et al.
Publicado: (2023) -
The LoCo (Lockdown Cohort)-effect: why the LoCo may have better life prospects than previous and subsequent birth cohorts
por: Oberndorfer, Moritz, et al.
Publicado: (2022) -
EUFOREA Comment on a Misleading Allergic Rhinitis Report [Response to Letter]
por: Fifer, Simon, et al.
Publicado: (2023) -
El loco
por: Goetz, Rainald